These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 25856229)

  • 21. High-throughput docking for the identification of new influenza A virus polymerase inhibitors targeting the PA-PB1 protein-protein interaction.
    Tintori C; Laurenzana I; Fallacara AL; Kessler U; Pilger B; Stergiou L; Botta M
    Bioorg Med Chem Lett; 2014 Jan; 24(1):280-2. PubMed ID: 24314669
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A peptide derived from the C-terminus of PB1 inhibits influenza virus replication by interfering with viral polymerase assembly.
    Li C; Ba Q; Wu A; Zhang H; Deng T; Jiang T
    FEBS J; 2013 Feb; 280(4):1139-49. PubMed ID: 23279951
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Design, synthesis, and in vitro biological evaluation of 1H-1,2,3-triazole-4-carboxamide derivatives as new anti-influenza A agents targeting virus nucleoprotein.
    Cheng H; Wan J; Lin MI; Liu Y; Lu X; Liu J; Xu Y; Chen J; Tu Z; Cheng YS; Ding K
    J Med Chem; 2012 Mar; 55(5):2144-53. PubMed ID: 22332894
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fragment-Based Identification of Influenza Endonuclease Inhibitors.
    Credille CV; Chen Y; Cohen SM
    J Med Chem; 2016 Jul; 59(13):6444-54. PubMed ID: 27291165
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of influenza virus inhibitors which disrupt of viral polymerase protein-protein interactions.
    Chase G; Wunderlich K; Reuther P; Schwemmle M
    Methods; 2011 Oct; 55(2):188-91. PubMed ID: 21867756
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of a novel compound with antiviral activity against influenza A virus depending on PA subunit of viral RNA polymerase.
    Yamada K; Koyama H; Hagiwara K; Ueda A; Sasaki Y; Kanesashi SN; Ueno R; Nakamura HK; Kuwata K; Shimizu K; Suzuki M; Aida Y
    Microbes Infect; 2012 Aug; 14(9):740-7. PubMed ID: 22441116
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chemical Genomics Approach Leads to the Identification of Hesperadin, an Aurora B Kinase Inhibitor, as a Broad-Spectrum Influenza Antiviral.
    Hu Y; Zhang J; Musharrafieh R; Hau R; Ma C; Wang J
    Int J Mol Sci; 2017 Sep; 18(9):. PubMed ID: 28885544
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular basis of the interaction for an essential subunit PA-PB1 in influenza virus RNA polymerase: insights from molecular dynamics simulation and free energy calculation.
    Liu H; Yao X
    Mol Pharm; 2010 Feb; 7(1):75-85. PubMed ID: 19883112
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Crystal structure of the polymerase PA(C)-PB1(N) complex from an avian influenza H5N1 virus.
    He X; Zhou J; Bartlam M; Zhang R; Ma J; Lou Z; Li X; Li J; Joachimiak A; Zeng Z; Ge R; Rao Z; Liu Y
    Nature; 2008 Aug; 454(7208):1123-6. PubMed ID: 18615018
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Discovery of dapivirine, a nonnucleoside HIV-1 reverse transcriptase inhibitor, as a broad-spectrum antiviral against both influenza A and B viruses.
    Hu Y; Zhang J; Musharrafieh RG; Ma C; Hau R; Wang J
    Antiviral Res; 2017 Sep; 145():103-113. PubMed ID: 28778830
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Discovery of a novel, first-in-class, orally bioavailable azaindole inhibitor (VX-787) of influenza PB2.
    Clark MP; Ledeboer MW; Davies I; Byrn RA; Jones SM; Perola E; Tsai A; Jacobs M; Nti-Addae K; Bandarage UK; Boyd MJ; Bethiel RS; Court JJ; Deng H; Duffy JP; Dorsch WA; Farmer LJ; Gao H; Gu W; Jackson K; Jacobs DH; Kennedy JM; Ledford B; Liang J; Maltais F; Murcko M; Wang T; Wannamaker MW; Bennett HB; Leeman JR; McNeil C; Taylor WP; Memmott C; Jiang M; Rijnbrand R; Bral C; Germann U; Nezami A; Zhang Y; Salituro FG; Bennani YL; Charifson PS
    J Med Chem; 2014 Aug; 57(15):6668-78. PubMed ID: 25019388
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of influenza polymerase inhibitors targeting C-terminal domain of PA through surface plasmon resonance screening.
    Lo CY; Li OT; Tang WP; Hu C; Wang GX; Ngo JC; Wan DC; Poon LL; Shaw PC
    Sci Rep; 2018 Feb; 8(1):2280. PubMed ID: 29396435
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Packaging signals in the 5'-ends of influenza virus PA, PB1, and PB2 genes as potential targets to develop nucleic-acid based antiviral molecules.
    Giannecchini S; Wise HM; Digard P; Clausi V; Del Poggetto E; Vesco L; Puzelli S; Donatelli I; Azzi A
    Antiviral Res; 2011 Oct; 92(1):64-72. PubMed ID: 21741410
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A single E105K mutation far from the active site of influenza B virus neuraminidase contributes to reduced susceptibility to multiple neuraminidase-inhibitor drugs.
    Fujisaki S; Takashita E; Yokoyama M; Taniwaki T; Xu H; Kishida N; Sato H; Tashiro M; Imai M; Odagiri T
    Biochem Biophys Res Commun; 2012 Dec; 429(1-2):51-6. PubMed ID: 23131559
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Focusing on the Influenza Virus Polymerase Complex: Recent Progress in Drug Discovery and Assay Development.
    Zhang J; Hu Y; Musharrafieh R; Yin H; Wang J
    Curr Med Chem; 2019; 26(13):2243-2263. PubMed ID: 29984646
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The fight against the influenza A virus H1N1: synthesis, molecular modeling, and biological evaluation of benzofurazan derivatives as viral RNA polymerase inhibitors.
    Pagano M; Castagnolo D; Bernardini M; Fallacara AL; Laurenzana I; Deodato D; Kessler U; Pilger B; Stergiou L; Strunze S; Tintori C; Botta M
    ChemMedChem; 2014 Jan; 9(1):129-50. PubMed ID: 24285596
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nucleoprotein of influenza B virus binds to its type A counterpart and disrupts influenza A viral polymerase complex formation.
    Jaru-ampornpan P; Narkpuk J; Wanitchang A; Jongkaewwattana A
    Biochem Biophys Res Commun; 2014 Jan; 443(1):296-300. PubMed ID: 24309113
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Optimization of small-molecule inhibitors of influenza virus polymerase: from thiophene-3-carboxamide to polyamido scaffolds.
    Lepri S; Nannetti G; Muratore G; Cruciani G; Ruzziconi R; Mercorelli B; Palù G; Loregian A; Goracci L
    J Med Chem; 2014 May; 57(10):4337-50. PubMed ID: 24785979
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficient and regioselective one-step synthesis of 7-aryl-5-methyl- and 5-aryl-7-methyl-2-amino-[1,2,4]triazolo[1,5-a]pyrimidine derivatives.
    Massari S; Desantis J; Nannetti G; Sabatini S; Tortorella S; Goracci L; Cecchetti V; Loregian A; Tabarrini O
    Org Biomol Chem; 2017 Sep; 15(37):7944-7955. PubMed ID: 28902220
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Human cytomegalovirus inhibitor AL18 also possesses activity against influenza A and B viruses.
    Muratore G; Mercorelli B; Goracci L; Cruciani G; Digard P; Palù G; Loregian A
    Antimicrob Agents Chemother; 2012 Nov; 56(11):6009-13. PubMed ID: 22908168
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.